The recombinant human endostatin market is driving due to government initiatives to reduce prices of
Increasing research and development activities for identifying potential uses of recombinant human endostatin is expected to propel growth of the market. For instance, according to a paper published in the journal Nature, September 2015, a study was conducted to evaluate effects of recombinant human endostatin in combination with radiotherapy for treating esophageal squamous cell carcinoma and to discover its potential mechanisms. These findings suggested that recombinant human endostatin is a potential anti-angiogenic agent in esophageal squamous cell carcinoma mainly when combined with radiotherapy.
Related Bookmarks
- Medical Courier Services
- The global processed food market is segmented on the basis of process, products, and application.
- Stony Patch Edibles: What are they?
- Non-Hodgkins Lymphoma Treatment Market, 2018-2026 � Market Estimate, Competitive Landscape, Industry
- A Begineer Guide ot White OG Strain
- New Science on the Health Benefits of Melatonin 10 mg
- Leishmaniasis Treatment Market is driven by the adoption of new methods and treatments by pharmaceut
- What's Naturopathic Medicine and How it is Different from Holistic Medicines
- Kamagra Online
- Home Healthcare Services Are Used For People Who Need Constant Care And Cannot Be Admitted To A Heal
Recent Profiles
Jun88
Buzz Cars
Go8
Luck8
Dandekeps
Hines Cowan
Baofn Compressor
New Star Home Health Care
Sivakumar Palaniappan
99ok